7.59

2.71% 0.20

After Hours: 7.56 -0.03 -0.40%

Wave Life Sciences Ltd (WVE)

Overview News Price History Option Chain Financials Why WVE Down? Discussions Forecast

Wave Life Sciences Ltd stock is traded at $7.59, with a volume of 3.45M. It is up +2.71% in the last 24 hours and down -41.71% over the past month. WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Previous Close:

$7.39

Open:

$7.48

24h Volume:

3.45M

Relative Volume:

0.83

Market Cap:

$1.43B

Revenue:

$42.73M

Net Income/Loss:

$-204.38M

P/E Ratio:

-6.2603

EPS:

-1.2124

Net Cash Flow:

$-189.73M

1W Performance:

+6.90%

1M Performance:

-41.71%

6M Performance:

-6.18%

1Y Performance:

+20.86%

1-Day Range:

$7.30

$7.74

1-Week Range:

$6.97

$7.74

52-Week Range:

$5.02

$21.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Name

Wave Life Sciences Ltd

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

617-949-2900

Address

7 STRAITS VIEW, SINGAPORE

Employee

317

Twitter

@WAVELifeSci

Next Earnings Date

2025-03-04

Latest SEC Filings

WVE's Discussions on Twitter

Compare WVE vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WVE Wave Life Sciences Ltd	7.59	1.39B	42.73M	-204.38M	-189.73M	-1.2124
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-05-26	Initiated	BofA Securities	Buy
Dec-12-25	Reiterated	Wedbush	Outperform
Dec-09-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Oct-20-25	Initiated	Wells Fargo	Overweight
Aug-04-25	Initiated	Canaccord Genuity	Buy
Jul-28-25	Initiated	Oppenheimer	Outperform
Jul-16-25	Initiated	Citigroup	Buy
Jun-11-25	Resumed	Raymond James	Outperform
Apr-29-25	Initiated	Cantor Fitzgerald	Overweight
Apr-08-25	Initiated	Wedbush	Outperform
Feb-25-25	Initiated	Jefferies	Buy
Oct-16-24	Upgrade	Raymond James	Outperform → Strong Buy
Sep-27-24	Resumed	JP Morgan	Overweight
Sep-19-24	Initiated	B. Riley Securities	Buy
Sep-09-24	Initiated	JP Morgan	Overweight
May-15-24	Initiated	Wells Fargo	Overweight
Dec-19-23	Upgrade	Leerink Partners	Market Perform → Outperform
Jul-05-23	Initiated	Raymond James	Outperform
May-24-23	Downgrade	Jefferies	Buy → Hold
Dec-15-20	Resumed	H.C. Wainwright	Buy
Oct-23-20	Initiated	RBC Capital Mkts	Sector Perform
Dec-31-19	Downgrade	SVB Leerink	Outperform → Mkt Perform
Nov-01-19	Initiated	Guggenheim	Buy
Jul-15-19	Initiated	Cowen	Market Perform
Apr-17-19	Reiterated	H.C. Wainwright	Buy
Aug-07-18	Initiated	Stifel	Buy
Jul-23-18	Initiated	H.C. Wainwright	Buy
Mar-19-18	Reiterated	Mizuho	Buy
Feb-15-17	Initiated	H.C. Wainwright	Buy
Nov-10-16	Resumed	Leerink Partners	Outperform
Dec-07-15	Initiated	JMP Securities	Mkt Outperform
Dec-07-15	Initiated	Jefferies	Buy
Dec-07-15	Initiated	Leerink Partners	Outperform
Dec-07-15	Initiated	Sun Trust Rbsn Humphrey	Buy

View All

Wave Life Sciences Ltd Stock (WVE) Latest News

04:34 AM

Wave Life Sciences plans redomicile from Singapore to U.S. - Investing.com

04:34 AM

04:32 AM

Wave Life Sciences Plans Redomiciling to Delaware Corporation - TipRanks

04:32 AM

04:13 AM

Wave Life Sciences plans redomicile from Singapore to U.S. By Investing.com - Investing.com Canada

04:13 AM

04:08 AM

Wave Life Sciences (Nasdaq: WVE) sets tax-free U.S. redomiciliation - Stock Titan

04:08 AM

04:01 AM

Wave Life Sciences seeks Delaware move to cut compliance costs - Stock Titan

04:01 AM

Apr 14, 2026

Jefferies Maintains “Buy” Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning - MSN

Apr 14, 2026

WVE Maintains Rating by HC Wainwright & Co. -- Price Target Lowe - GuruFocus

Apr 14, 2026

WVE Maintains Rating by HC Wainwright & Co. -- Price Target Lowered to $18 - GuruFocus

Apr 14, 2026

Wave Life Sciences (WVE) price target decreased by 20.34% to 28.29 - MSN

Apr 14, 2026

Apr 12, 2026

RBC Capital Maintains Outperform Rating on Wave Life Sciences (WVE) - Yahoo Finance

Apr 12, 2026

Apr 10, 2026

Q1 2025 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus

Apr 10, 2026

WVE Stock Price, Quote & Chart | WAVE LIFE SCIENCES LTD (NASDAQ:WVE) - ChartMill

Apr 10, 2026

Apr 09, 2026

Wave Life Sciences plunges after early-stage data for obesity therapy - MSN

Apr 09, 2026

Apr 08, 2026

Wave Life Sciences Ltd. R (1U5.DU) Q1 FY2025 earnings call transcript - Yahoo Finance

Apr 08, 2026

Apr 07, 2026

RBC Capital Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $15 - Moomoo

Apr 07, 2026

RBC Capital Adjusts Wave Life Sciences PT to $15 From $27, Maintains Outperform Rating - Moomoo

Apr 07, 2026